NIH experts call for transformative research approach to end tuberculosis

March 9, 2018, NIH/National Institute of Allergy and Infectious Diseases
This photomicrograph reveals Mycobacterium tuberculosis bacteria using acid-fast Ziehl-Neelsen stain; Magnified 1000 X. The acid-fast stains depend on the ability of mycobacteria to retain dye when treated with mineral acid or an acid-alcohol solution such as the Ziehl-Neelsen, or the Kinyoun stains that are carbolfuchsin methods specific for M. tuberculosis. Credit: public domain

A more intensive biomedical research approach is necessary to control and ultimately eliminate tuberculosis (TB), according to a perspective published in the March 2018 issue of The American Journal of Tropical Medicine and Hygiene. In the article, authors Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and Robert W. Eisinger, Ph.D., special assistant for scientific projects at NIAID, discuss the need to modernize TB research by applying new diagnostic, therapeutic, and vaccine approaches. The perspective is based on a lecture delivered by Dr. Fauci on Nov. 17, 2017 in Moscow at the first World Health Organization Global Ministerial Conference, "Ending TB in the Sustainable Development Era: A Multisectoral Response."

TB, a bacterial infection that typically infects the lungs, is one of the oldest known human diseases and the leading infectious cause of death worldwide. The authors recall the significant HIV/AIDS research advances made in the nearly 37 years since AIDS was first recognized, and encourage the scientific community to strive for comparable TB milestones.

Specifically, the authors call for systems biology approaches (using large data sets and modeling to understand ) to fill critical knowledge gaps in understanding how Mycobacterium tuberculosis (Mtb) infection causes . Such research could help explain why some people infected with Mtb have latent infections and show no signs of disease while others, especially those co-infected with HIV, become sick. The perspective also underscores the need for improved diagnostic tests, including those that can detect Mtb in various specimens as well as rapid, inexpensive tests that can detect drug-resistant TB.

Lengthy and complex treatment regimens and an increasing number of multi-drug-resistant TB infections make the disease increasingly difficult to cure. The authors note that the ultimate treatment goal should be drug combinations administered for shorter time periods that can cure people infected with any strain of Mtb. Another research goal is a safe and more broadly effective vaccine, which remains one of the most difficult challenges, according to Drs. Fauci and Eisinger. However, they explain, a vaccine and other significant advances are possible with an innovative and aggressive biomedical research program and rapid translation of results into global control strategies.

Explore further: Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

More information: Anthony S. Fauci et al, Reimagining the Research Approach to Tuberculosis †, The American Journal of Tropical Medicine and Hygiene (2018). DOI: 10.4269/ajtmh.17-0999

Related Stories

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

October 9, 2017
Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV/AIDS pandemic, according to a new commentary ...

Monoclonal antibodies crucial to fighting emerging infectious diseases

March 8, 2018
Monoclonal antibodies (mAbs)—preparations of a specific type of antibody designed to bind to a single target—have shown promise in the fight against cancer and autoimmune diseases. They also may play a critical role in ...

One-month TB prophylaxis as effective as nine-month regimen for people living with HIV

March 5, 2018
A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people living with HIV, according to the results of a large international ...

Durable end to AIDS will require HIV vaccine development

February 5, 2014
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately ...

Strategic plan for developing a universal influenza vaccine

February 28, 2018
Developing a universal influenza vaccine—a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic—is a priority for the National ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.